dc.contributor.author | Brobak, Karl Marius | |
dc.contributor.author | Andreassen, Runa Marie | |
dc.contributor.author | Melsom, Toralf | |
dc.contributor.author | Høieggen, Aud | |
dc.contributor.author | Norvik, Jon Viljar | |
dc.contributor.author | Solbu, Marit Dahl | |
dc.date.accessioned | 2022-10-06T10:41:51Z | |
dc.date.available | 2022-10-06T10:41:51Z | |
dc.date.issued | 2022-10-03 | |
dc.description.abstract | Purpose: Subclinical chronic kidney disease is known to exacerbate hypertension and progression of kidney damage. In order to initiate timely interventions, early biomarkers for this vicious
circle are needed. Our aim was to describe the cross-sectional associations of urinary orosomucoid and urinary N-acetyl-b-D-glucosaminidase (NAG) with blood pressure and the longitudinal
associations of urinary orosomucoid and NAG to hypertension after 7 years, and to compare the
strength of these associations to the urinary albumin excretion (UAE).<p>
<p>Material and methods: The Tromsø Study is a population-based, prospective study of inhabitants of the municipality of Tromsø, Northern Norway. Morning spot urine samples were collected on three consecutive days in the Tromsø 6 survey (2007–2008). We assessed the crosssectional associations of urinary orosomucoid, NAG and UAE with blood pressure in Tromsø 6.
In a cohort of participants attending Tromsø 6 and Tromsø 7 (2015–2016), we studied whether
urinary biomarkers were longitudinally associated with hypertension.
<p>Results: A total of 7197 participants with a mean age of 63.5 years (SD 9.2), and a mean blood
pressure of 141/78 mmHg (SD 23.0/10.6), were included in the study. Orosomucoid and UAE,
but not NAG, was significantly associated with systolic and diastolic blood pressure in all the
crude and multivariable cross-sectional analyses. Orosomucoid had consistently, although marginally, stronger associations with blood pressure. Incident hypertension at follow-up (Tromsø 7)
was consistently significantly associated with urinary orosomucoid, but not urinary NAG or UAE.
However, the standardized regression coefficients for orosomucoid were only marginally stronger than the standardized regression coefficients for ACR.
<p>Conclusion: In a cohort from the general population urine orosomucoid had a stronger crosssectional association with blood pressure than UAE. After 7 years, urine orosomucoid showed
the strongest association with incident hypertension. There were varying and weak associations
between U-NAG, blood pressure and hypertension. | en_US |
dc.identifier.citation | Brobak KM, Andreassen, Melsom, Høieggen, Norvik, Solbu. Associations of urinary orosomucoid, N-acetyl-β-D-glucosaminidase, and albumin with blood pressure and hypertension during 7 years of follow-up. The Tromsø Stud. Blood Pressure. 2022 | en_US |
dc.identifier.cristinID | FRIDAID 2054340 | |
dc.identifier.doi | 10.1080/08037051.2022.2128043 | |
dc.identifier.issn | 0803-7051 | |
dc.identifier.issn | 1651-1999 | |
dc.identifier.uri | https://hdl.handle.net/10037/26986 | |
dc.language.iso | eng | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.relation.ispartof | Brobak, K.M. (2024). Novel biomarkers in hypertension. (Doctoral thesis). <a href=https://hdl.handle.net/10037/33114>https://hdl.handle.net/10037/33114</a>. | |
dc.relation.journal | Blood Pressure | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2022 The Author(s) | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | en_US |
dc.rights | Attribution 4.0 International (CC BY 4.0) | en_US |
dc.title | Associations of urinary orosomucoid, N-acetyl-β-D-glucosaminidase, and albumin with blood pressure and hypertension during 7 years of follow-up. The Tromsø Study | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |